<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38317802</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Co-occurrence of bacteria and viruses and serotype distribution of <i>Streptococcus pneumoniae</i> in the nasopharynx of Tanzanian children below 2 years of age following introduction of the PCV13.</ArticleTitle><Pagination><StartPage>1298222</StartPage><MedlinePgn>1298222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1298222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1298222</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Pneumococcal conjugate vaccines have reduced severe disease attributed to vaccine-type pneumococci in children. However, the effect is dependent on serotype distribution in the population and disease development may be influenced by co-occurrence of viral and bacterial pathogens in the nasopharynx.</AbstractText><AbstractText Label="METHODS">Following introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in Tanzania we performed repeated cross-sectional surveys, including 775 children below 2 years of age attending primary healthcare centers. All children were sampled from nasopharynx and pneumococci were detected by single-target PCR. Pneumococcal serotypes/groups and presence of viruses and other bacteria were determined by two multiplex PCR assays.</AbstractText><AbstractText Label="RESULTS">The prevalence of PCV13 vaccine-type pneumococci decreased by 50%, but residual vaccine-types were still detected in 21% of the children 2 years after PCV13 introduction. An increase in the non-vaccine-type 15 BC was observed. Pneumococci were often co-occurring with <i>Haemophilus influenzae</i>, and detection of rhino/enterovirus was associated with higher pneumococcal load.</AbstractText><AbstractText Label="DISCUSSION">We conclude that presence of residual vaccine-type and emerging non-vaccine-type pneumococci in Tanzanian children demand continued pneumococcal surveillance. High co-occurrence of viral and bacterial pathogens may contribute to the disease burden and indicate the need of multiple public health interventions to improve child health in Tanzania.</AbstractText><CopyrightInformation>Copyright © 2024 Emgård, Andersson, Gonzales-Siles, Msuya, Nyombi, Nordén, Muro, Lindh, Andersson and Skovbjerg.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emgård</LastName><ForeName>Matilda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales-Siles</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Msuya</LastName><ForeName>Sia E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyombi</LastName><ForeName>Balthazar M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordén</LastName><ForeName>Rickard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muro</LastName><ForeName>Florida</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Medicine, Kilimanjaro Christian Medical Center (KCMC), Moshi, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindh</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Rune</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skovbjerg</LastName><ForeName>Susann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="Y">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002353" MajorTopicYN="N">Carrier State</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword><Keyword MajorTopicYN="N">infant</Keyword><Keyword MajorTopicYN="N">pneumococcal conjugate vaccines</Keyword><Keyword MajorTopicYN="N">sub-Saharan Africa</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38317802</ArticleId><ArticleId IdType="pmc">PMC10839969</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1298222</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bar-Zeev N, Swarthout TD, Everett DB, Alaerts M, Msefula J, Brown C, et al. . Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies. Lancet Glob Health. (2021) 9:e989–98. doi: 10.1016/S2214-109X(21)00165-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00165-0</ArticleId><ArticleId IdType="pmc">PMC8220129</ArticleId><ArticleId IdType="pubmed">34143997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie GA, Hill PC, Sahito SM, Jeffries DJ, Hossain I, Bottomley C, et al. . Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in the Gambia: population-based surveillance and case-control studies. Lancet Infect Dis. (2017) 17:965–73. doi: 10.1016/S1473-3099(17)30321-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30321-3</ArticleId><ArticleId IdType="pmc">PMC5589209</ArticleId><ArticleId IdType="pubmed">28601421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pneumonia Etiology Research for Child Health (PERCH) Study Group . Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. (2019) 394:757–79. doi: 10.1016/S0140-6736(19)30721-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30721-4</ArticleId><ArticleId IdType="pmc">PMC6727070</ArticleId><ArticleId IdType="pubmed">31257127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. . Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. (2018) 6:e744–57. doi: 10.1016/S2214-109X(18)30247-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(18)30247-X</ArticleId><ArticleId IdType="pmc">PMC6005122</ArticleId><ArticleId IdType="pubmed">29903376</ArticleId></ArticleIdList></Reference><Reference><Citation>Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, O'Brien KL. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. (2012) 11:841–55. doi: 10.1586/erv.12.53, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.12.53</ArticleId><ArticleId IdType="pubmed">22913260</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, et al. . Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. (2006) 194:682–8. doi: 10.1086/505710, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/505710</ArticleId><ArticleId IdType="pubmed">16897668</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. (2006) 19:571–82. doi: 10.1128/CMR.00058-05, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00058-05</ArticleId><ArticleId IdType="pmc">PMC1539103</ArticleId><ArticleId IdType="pubmed">16847087</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink G, D'Acremont V, Leslie HH, Cohen J. Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys. Lancet Infect Dis. (2020) 20:179–87. doi: 10.1016/S1473-3099(19)30572-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30572-9</ArticleId><ArticleId IdType="pubmed">31843383</ArticleId></ArticleIdList></Reference><Reference><Citation>Emgard M, Msuya SE, Nyombi BM, Mosha D, Gonzales-Siles L, Norden R, et al. . Carriage of penicillin-non-susceptible pneumococci among children in northern Tanzania in the 13-valent pneumococcal vaccine era. Int J Infect Dis. (2019) 81:156–66. doi: 10.1016/j.ijid.2019.01.035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.01.035</ArticleId><ArticleId IdType="pubmed">30685588</ArticleId></ArticleIdList></Reference><Reference><Citation>Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. . Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group. Vaccine. (2013) 32:165–79. doi: 10.1016/j.vaccine.2013.08.062, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.062</ArticleId><ArticleId IdType="pubmed">24331112</ArticleId></ArticleIdList></Reference><Reference><Citation>Salva-Serra F, Connolly G, Moore ERB, Gonzales-Siles L. Detection of "Xisco" gene for identification of Streptococcus pneumoniae isolates. Diagn Microbiol Infect Dis. (2018) 90:248–50. doi: 10.1016/j.diagmicrobio.2017.12.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.12.003</ArticleId><ArticleId IdType="pubmed">29329755</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales-Siles L, Karlsson R, Schmidt P, Salvà-Serra F, Jaén-Luchoro D, Skovbjerg S, et al. . A Pangenome approach for discerning species-unique gene markers for identifications of Streptococcus pneumoniae and Streptococcus pseudopneumoniae. Front Cell Infect Microbiol. (2020) 10:222. doi: 10.3389/fcimb.2020.00222, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00222</ArticleId><ArticleId IdType="pmc">PMC7248185</ArticleId><ArticleId IdType="pubmed">32509595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen CB, Fuursted K, Valentiner-Branth P, Dalby T, Jørgensen CS, Slotved HC. Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 8 in Denmark. BMC Infect Dis. (2021) 21:421. doi: 10.1186/s12879-021-06103-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06103-w</ArticleId><ArticleId IdType="pmc">PMC8097992</ArticleId><ArticleId IdType="pubmed">33952197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales-Siles L, Salvà-Serra F, Degerman A, Nordén R, Lindh M, Skovbjerg S, et al. . Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains. J Med Microbiol. (2019) 68:1173–88. doi: 10.1099/jmm.0.001022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001022</ArticleId><ArticleId IdType="pubmed">31268417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine. (2011) 29:7207–11. doi: 10.1016/j.vaccine.2011.06.056, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.06.056</ArticleId><ArticleId IdType="pmc">PMC3170457</ArticleId><ArticleId IdType="pubmed">21689707</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson ME, Olofsson S, Lindh M. Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection. Scand J Infect Dis. (2014) 46:897–901. doi: 10.3109/00365548.2014.951681, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2014.951681</ArticleId><ArticleId IdType="pubmed">25288382</ArticleId></ArticleIdList></Reference><Reference><Citation>Usuf E, Bottomley C, Gladstone R, Bojang E, Jawneh K, Cox I, et al. . Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after 10 years of pneumococcal conjugate vaccine pressure. Clin Infect Dis. (2021) 73:e3825–35. doi: 10.1093/cid/ciaa856</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa856</ArticleId><ArticleId IdType="pubmed">32584973</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarthout TD, Fronterre C, Lourenço J, Obolski U, Gori A, Bar-Zeev N, et al. . High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi. Nat Commun. (2020) 11:2222. doi: 10.1038/s41467-020-15786-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15786-9</ArticleId><ArticleId IdType="pmc">PMC7203201</ArticleId><ArticleId IdType="pubmed">32376860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP, Danis K, et al. . Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries. Europe Emerg Infect Dis. (2022) 28:137–8. doi: 10.3201/eid2801.210734</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2801.210734</ArticleId><ArticleId IdType="pmc">PMC8714201</ArticleId><ArticleId IdType="pubmed">34932457</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, et al. . Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in the Gambia: a population-based surveillance study. Lancet Infect Dis. (2016) 16:703–11. doi: 10.1016/S1473-3099(16)00054-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00054-2</ArticleId><ArticleId IdType="pmc">PMC4909992</ArticleId><ArticleId IdType="pubmed">26897105</ArticleId></ArticleIdList></Reference><Reference><Citation>Quesada MG, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, et al. . Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE project. Microorganisms. (2021) 9:738. doi: 10.3390/microorganisms9040738</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9040738</ArticleId><ArticleId IdType="pmc">PMC8066874</ArticleId><ArticleId IdType="pubmed">33916227</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarthout TD, Ibarz-Pavon A, Kawalazira G, Sinjani G, Chirombo J, Gori A, et al. . A pragmatic health Centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+0 to 2+1 in a high pneumococcal carriage and disease burden setting in Malawi: a study protocol. BMJ Open. (2021) 11:e050312. doi: 10.1136/bmjopen-2021-050312, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050312</ArticleId><ArticleId IdType="pmc">PMC8212416</ArticleId><ArticleId IdType="pubmed">34140345</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N, Di Cara G, Bizzarri I, Isidori C, Borgia P, Mignini C, et al. . Prevention of invasive pneumococcal disease: problems emerged after some years of the 13-valent pneumococcal conjugate vaccine use. Curr Infect Dis Rep. (2018) 20:1. doi: 10.1007/s11908-018-0607-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-018-0607-z</ArticleId><ArticleId IdType="pubmed">29368250</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfving K, Strömberg LG, Geravandi S, Andersson M, Bachelard M, Msellem M, et al. . Pneumococcal concentration and serotype distribution in preschool children with radiologically confirmed pneumonia compared to healthy controls prior to introduction of pneumococcal vaccination in Zanzibar: an observational study. BMC Infect Dis. (2022) 22:925. doi: 10.1186/s12879-022-07902-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07902-5</ArticleId><ArticleId IdType="pmc">PMC9737767</ArticleId><ArticleId IdType="pubmed">36496395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammitt LL, Akech DO, Morpeth SC, Karani A, Kihuha N, Nyongesa S, et al. . Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. (2014) 2:e397–405. doi: 10.1016/S2214-109X(14)70224-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(14)70224-4</ArticleId><ArticleId IdType="pmc">PMC5628631</ArticleId><ArticleId IdType="pubmed">25103393</ArticleId></ArticleIdList></Reference><Reference><Citation>Skosana Z, Von Gottberg A, Olorunju S, Mohale T, Du Plessis M, Adams T, et al. . Non-vaccine serotype pneumococcal carriage in healthy infants in South Africa following introduction of the 13-valent pneumococcal conjugate vaccine. S Afr Med J. (2021) 111:143–8. doi: 10.7196/SAMJ.2021.v111i2.14626, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2021.v111i2.14626</ArticleId><ArticleId IdType="pubmed">33944725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, et al. . Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis. (2019) 19:759–69. doi: 10.1016/S1473-3099(19)30297-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30297-X</ArticleId><ArticleId IdType="pmc">PMC7641901</ArticleId><ArticleId IdType="pubmed">31196809</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfving K, Shakely D, Andersson M, Baltzell K, Ali AS, Bachelard M, et al. . Acute uncomplicated febrile illness in children aged 2-59 months in Zanzibar - Aetiologies, antibiotic treatment and outcome. PLoS One. (2016) 11:e0146054. doi: 10.1371/journal.pone.0146054, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0146054</ArticleId><ArticleId IdType="pmc">PMC4731140</ArticleId><ArticleId IdType="pubmed">26821179</ArticleId></ArticleIdList></Reference><Reference><Citation>Thors V, Christensen H, Morales-Aza B, Oliver E, Sikora P, Vipond I, et al. . High-density bacterial nasal carriage in children is transient and associated with respiratory viral infections-implications for transmission dynamics. Pediatr Infect Dis J. (2019) 38:533–8. doi: 10.1097/INF.0000000000002256, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002256</ArticleId><ArticleId IdType="pubmed">30985547</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett HC, Watson NL, Deloria Knoll M, Brooks WA, Feikin DR, Hammitt LL, et al. . Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged &lt;5 years in the PERCH study. Clin Infect Dis. (2017) 64:S317–s27. doi: 10.1093/cid/cix100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix100</ArticleId><ArticleId IdType="pmc">PMC5850437</ArticleId><ArticleId IdType="pubmed">28575365</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, et al. . Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. (2019) 7:e1031–45. doi: 10.1016/S2214-109X(19)30264-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(19)30264-5</ArticleId><ArticleId IdType="pubmed">31303294</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna S, McAuley J, Jacobson J, Nguyen CD, Ullah MA, Sebina I, et al. . Synergism and antagonism of bacterial-viral coinfection in the upper respiratory tract. mSphere. (2022) 7:e0098421. doi: 10.1128/msphere.00984-21, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00984-21</ArticleId><ArticleId IdType="pmc">PMC8769199</ArticleId><ArticleId IdType="pubmed">35044807</ArticleId></ArticleIdList></Reference><Reference><Citation>Grijalva CG, Griffin MR, Edwards KM, Johnson M, Gil AI, Verastegui H, et al. . Concordance between RT-PCR-based detection of respiratory viruses from nasal swabs collected for viral testing and nasopharyngeal swabs collected for bacterial testing. J Clin Virol. (2014) 60:309–12. doi: 10.1016/j.jcv.2014.04.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.04.011</ArticleId><ArticleId IdType="pmc">PMC4055503</ArticleId><ArticleId IdType="pubmed">24875136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngocho JS, Minja L, van der Gaast-de Jongh CE, Rahamat-Langendoen JC, Langereis JD, Mmbaga BT, et al. . Viral-bacterial (co-)occurrence in the upper airways and the risk of childhood pneumonia in resource-limited settings. J Infect. (2020) 81:213–20. doi: 10.1016/j.jinf.2020.06.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7392802</ArticleId><ArticleId IdType="pubmed">32533999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildenwall H, Lindkvist J, Tumwine JK, Bergqvist Y, Pariyo G, Tomson G, et al. . Low validity of caretakers' reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda. Trans R Soc Trop Med Hyg. (2009) 103:95–101. doi: 10.1016/j.trstmh.2008.04.046, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2008.04.046</ArticleId><ArticleId IdType="pubmed">18678381</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>